Quick Comparison

NAC (N-Acetyl Cysteine)Nicotine
Half-Life5.6 hours1-2 hours
Typical DosageStandard: 600-1800 mg daily in 2-3 divided doses. For psychiatric applications: 1200-2400 mg daily (under medical supervision). Take on an empty stomach for best absorption. Can cause nausea — take with a small amount of food if needed.Nootropic dose: 1-2 mg via gum, lozenge, or patch. Start with 0.5-1 mg if nicotine-naive. Patch: 7 mg patch cut into quarters (1.75 mg each). Use intermittently (2-3 times per week maximum) to avoid dependence.
AdministrationOral (capsules, powder). Take on empty stomach or with light food. Effervescent tablets also available.Transdermal (patch), buccal (gum, lozenge), nasal (spray). Avoid smoking and vaping — the delivery method matters for health.
Research Papers10 papers10 papers
Categories

Mechanism of Action

NAC (N-Acetyl Cysteine)

NAC provides cysteine, the rate-limiting substrate for glutathione (GSH) synthesis via gamma-glutamylcysteine ligase (GCLC) and glutathione synthetase (GSS). GSH is the primary intracellular antioxidant, essential for GPx and GST-mediated detoxification of reactive oxygen species in neurons. NAC also modulates glutamate via the cystine-glutamate antiporter (System Xc-, composed of xCT and 4F2hc) — NAC is deacetylated to cysteine, which exchanges for glutamate; the increased extracellular cystine is reduced to cysteine intracellularly, while the exchange increases extrasynaptic glutamate, which activates inhibitory mGlu2/3 autoreceptors on presynaptic terminals, reducing excessive glutamatergic signaling and compulsive behaviors. This glutamate modulation is the basis for psychiatric applications (OCD, addiction). NAC may also directly modulate NMDA receptors via redox sites.

Nicotine

Nicotine binds to nicotinic acetylcholine receptors (nAChRs), particularly the high-affinity alpha-4-beta-2 subtype predominant in the brain, causing conformational changes that open the cation channel and allow Na+ and Ca2+ influx, depolarizing the neuron. This triggers vesicular release of dopamine (VTA to nucleus accumbens and prefrontal cortex), norepinephrine (locus coeruleus), acetylcholine (basal forebrain), serotonin, and glutamate. Cognitive enhancement comes from increased acetylcholine in the prefrontal cortex and hippocampus (attention, working memory) and dopamine in mesocortical pathways (motivation, executive function). Nicotine upregulates BDNF through nAChR-mediated Ca2+ signaling and CREB activation, and has anti-inflammatory effects via microglial alpha-7 nAChRs. Neuroprotection may involve reduced excitotoxicity and enhanced neuronal survival pathways.

Risks & Safety

NAC (N-Acetyl Cysteine)

Common

Nausea, diarrhea, unpleasant sulfur smell/taste.

Serious

May be harmful in certain contexts — there is concern it could protect cancer cells from oxidative stress. May interact with nitroglycerin (dangerous blood pressure drop).

Rare

Bronchospasm in asthmatics (when inhaled).

Nicotine

Common

Nausea, dizziness, hiccups, jaw soreness (gum), skin irritation (patch). Addictive with daily use.

Serious

Cardiovascular strain — increases heart rate and blood pressure. Avoid with cardiovascular disease. Nicotine toxicity at high doses (>60 mg).

Rare

Seizures at toxic doses, severe allergic reactions.

Full Profiles